Janssen CAR-T Collaboration with Cellular Biomedicine Group Inc.

Sexton Riley LLP represented Janssen Biotech, Inc. in a worldwide collaboration and license agreement with Cellular Biomedicine Group Inc. for certain CAR T-cell therapies for the treatment of B-cell malignancies.

https://www.jnj.com/media-center/press-releases/janssen-enters-worldwide-collaboration-and-license-agreement-with-cellular-biomedicine-group-to-develop-next-generation-car-t-therapies